-+ 0.00%
-+ 0.00%
-+ 0.00%

Collegium Pharma director Michael Donovan files initial beneficial ownership statement

PUBT·05/18/2026 20:04:07
Listen to the news
Collegium Pharma director Michael Donovan files initial beneficial ownership statement
  • Collegium Pharmaceutical director Michael Donovan Glancy filed an initial Form 3 with the SEC dated May 14, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Collegium Pharmaceutical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002134015-26-000004), on May 18, 2026, and is solely responsible for the information contained therein.